T 2639/11 of 08.10.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T263911.20121008
- Date of decision
- 8 October 2012
- Case number
- T 2639/11
- Online on
- 19 October 2012
- Petition for review of
- -
- Application number
- 03253070.1
- IPC class
- C07D 401/12A61K 31/44
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Magnesium salt of s-omeprazole
- Applicant name
- SHERMAN, Bernard Charles
- Opponent name
- Teva Pharmaceutical Industries Ltd.
Hexal Aktiengesellschaft
STADA Arzneimittel AG
Krka, Tovarna Zdravil, d.d.
Mepha AG
Actavis Group hf. - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 101(1)
- Keywords
- Missing Statement of Grounds
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
The appeal is rejected as inadmissible.